In this study, we investigated the clinical utility of fMET and neutrophil activation markers in RA‐ILD patients and examined the role of fMET–FPR1 signaling in neutrophil activation, aiming to provide new mechanistic and translational insights. This evidence concerns the gene FPR1 and rheumatoid arthritis.